Clinical Trials Logo

Infections, Rotavirus clinical trials

View clinical trials related to Infections, Rotavirus.

Filter by:

NCT ID: NCT01563159 Completed - Clinical trials for Infections, Rotavirus

Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2010-2011

Start date: March 31, 2015
Phase: N/A
Study type: Observational

This study aims to confirm the statistically significant decline in rotavirus related and in acute gastro-enteritis (AGE) related hospital admissions that was observed in 11 participating hospitals, after the introduction of RV vaccines in Belgium in 2006.

NCT ID: NCT01563146 Completed - Clinical trials for Infections, Rotavirus

Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2006-2007

Start date: February 1, 2016
Phase: N/A
Study type: Observational

This study aims to collect data and assess the number of rotavirus related hospitalizations in 11 hospitals in Belgium - season 2006-2007 in order to develop proper age-cohort analysis over time.

NCT ID: NCT01435967 Completed - Clinical trials for Infections, Rotavirus

Observational Study on Rotavirus Gastroenteritis Epidemiology, Impact of Lyophilised vs. Liquid Formulation of Rotarix™

Start date: September 2011
Phase: N/A
Study type: Observational

The aim of this study is to monitor any impact in the change from the lyophilised formulation to the liquid formulation of the Rotarix™ vaccine on hospitalisations for rotavirus gastroenteritis. This is planned to be assessed by comparing trends of hospitalisations due to laboratory confirmed rotavirus gastroenteritis in children <=5 years of age, before and after introduction of the liquid formulation of the vaccine in Belgium.

NCT ID: NCT01339221 Completed - Clinical trials for Infections, Rotavirus

Epidemiological, Observational and Post Marketing Study of Rotarix™ in Children With Severe Gastroenteritis in Belgium

Start date: March 2011
Phase: N/A
Study type: Observational

The main aim of this study is to investigate cases of rotavirus gastroenteritis in Belgian children with opportunity to receive Rotarix™ to monitor the potential occurrence of genetic drifts (point mutations) in the vaccine strain and the occurrence of genetic shifts (re-assortments) between vaccine and naturally circulating wild-type strains in Belgium population after the introduction of Rotarix™. The study will also detect if there is any alteration in rotavirus pathogenicity conferred by re-assortment and if the mutated vaccine strain is still efficacious in preventing rotavirus gastroenteritis.

NCT ID: NCT01253967 Completed - Clinical trials for Infections, Rotavirus

Surveillance Study to Estimate the Proportion of Rotavirus Gastroenteritis in Children < 5 Years of Age in Romania

Start date: February 2008
Phase: N/A
Study type: Observational

The purpose of this hospital based study is to estimate the proportion of rotavirus gastroenteritis in children < 5 years of age in Romania.

NCT ID: NCT01198769 Completed - Clinical trials for Infections, Rotavirus

Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth.

Start date: November 11, 2010
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess immunogenicity and safety of Rotarix TM when administered in healthy Taiwanese infants (aged 6 to 12 weeks at the time of first vaccination) who received Hepatitis B immunoglobulin after birth.

NCT ID: NCT01177826 Completed - Clinical trials for Infections, Rotavirus

Effectiveness Study of GSK Biologicals' Rotarix TM Vaccine in Hospitalized Children

Start date: February 23, 2008
Phase:
Study type: Observational

The purpose of this study is to assess vaccine effectiveness of Rotarix in preventing rotavirus severe gastroenteritis among hospitalized infants, in Belgium.

NCT ID: NCT01171963 Completed - Clinical trials for Infections, Rotavirus

Study to Assess the Efficacy, Immunogenicity and Safety of Liquid Human Rotavirus Vaccine, in Healthy Chinese Infants

Start date: August 29, 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the efficacy, immunogenicity and safety of GSK Biologicals' liquid human rotavirus vaccine in healthy Chinese infants 6 to 16 weeks of age.

NCT ID: NCT01162590 Completed - Clinical trials for Infections, Rotavirus

Study to Evaluate the Reactogenicity and Safety of Rotarix™ in Chinese Adults

Start date: March 1, 2010
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety of Rotarix ™ when administered in healthy adults aged 18 to 45 years in China.

NCT ID: NCT01107587 Completed - Clinical trials for Infections, Rotavirus

Study to Assess the Safety of GSK Biologicals' Liquid Human Rotavirus Vaccine in Healthy Infants

Start date: April 13, 2010
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the reactogenicity and safety of GSK Biologicals' liquid human rotavirus vaccine in healthy infants aged 6 to 16 weeks at the time of the first dose of vaccination.